Generating Blood from iPS Cells View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2016

AUTHORS

Peter Karagiannis , Hiroshi Endo , Koji Eto

ABSTRACT

Blood transfusions are the oldest contemporary form of cell therapy and remain the standard treatment for anemia and thrombocytopenia. Due to the enucleate nature of the cells, patients that require erythrocyte or platelet transfusions must rely on a constant supply of blood donors. Aging populations and other demographic trends, however, make this dependency unsustainable. Consequently, investigators have sought other sources for these cell types. Despite only being discovered 10 years ago, induced pluripotent stem cells (iPSCs) have quickly gained the imagination of researchers seeking new clinical treatments for an assortment of diseases, including hematopathologies. The appeal of iPSCs is that they permit the conversion of any cell in the body to another type. This cell reprogramming makes it possible to conduct autologous transplantation by taking cells such as fibroblasts from the patient and converting them to erythrocytes or platelets before reintroduction. iPSCs also allow for investigations on hematopoiesis that were previously impossible, as they enable each intermediate step in the development of a blood cell to be controlled and therefore studied in greater detail. In this chapter, we review the basics about cell reprogramming to the iPSC state and the application of this technology to generating erythrocytes and platelets ex vivo. More... »

PAGES

399-420

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-39562-3_19

DOI

http://dx.doi.org/10.1007/978-3-319-39562-3_19

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1083691788


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karagiannis", 
        "givenName": "Peter", 
        "id": "sg:person.01312262664.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312262664.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Endo", 
        "givenName": "Hiroshi", 
        "id": "sg:person.0672274253.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672274253.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.258799.8", 
          "name": [
            "Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eto", 
        "givenName": "Koji", 
        "id": "sg:person.01062427654.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062427654.09"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2016", 
    "datePublishedReg": "2016-01-01", 
    "description": "Blood transfusions are the oldest contemporary form of cell therapy and remain the standard treatment for anemia and thrombocytopenia. Due to the enucleate nature of the cells, patients that require erythrocyte or platelet transfusions must rely on a constant supply of blood donors. Aging populations and other demographic trends, however, make this dependency unsustainable. Consequently, investigators have sought other sources for these cell types. Despite only being discovered 10 years ago, induced pluripotent stem cells (iPSCs) have quickly gained the imagination of researchers seeking new clinical treatments for an assortment of diseases, including hematopathologies. The appeal of iPSCs is that they permit the conversion of any cell in the body to another type. This cell reprogramming makes it possible to conduct autologous transplantation by taking cells such as fibroblasts from the patient and converting them to erythrocytes or platelets before reintroduction. iPSCs also allow for investigations on hematopoiesis that were previously impossible, as they enable each intermediate step in the development of a blood cell to be controlled and therefore studied in greater detail. In this chapter, we review the basics about cell reprogramming to the iPSC state and the application of this technology to generating erythrocytes and platelets ex vivo.", 
    "editor": [
      {
        "familyName": "Schulze", 
        "givenName": "Harald", 
        "type": "Person"
      }, 
      {
        "familyName": "Italiano", 
        "givenName": "Joseph", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-39562-3_19", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-39560-9", 
        "978-3-319-39562-3"
      ], 
      "name": "Molecular and Cellular Biology of Platelet Formation", 
      "type": "Book"
    }, 
    "keywords": [
      "pluripotent stem cells", 
      "iPSC state", 
      "cell reprogramming", 
      "iPS cells", 
      "assortment of diseases", 
      "cell types", 
      "stem cells", 
      "cells", 
      "constant supply", 
      "new clinical treatments", 
      "reprogramming", 
      "imagination of researchers", 
      "iPSCs", 
      "hematopoiesis", 
      "cell therapy", 
      "iPSCs", 
      "reintroduction", 
      "erythrocytes", 
      "fibroblasts", 
      "blood cells", 
      "vivo", 
      "greater detail", 
      "intermediate step", 
      "platelets", 
      "assortment", 
      "population", 
      "clinical treatment", 
      "types", 
      "development", 
      "demographic trends", 
      "autologous transplantation", 
      "body", 
      "disease", 
      "step", 
      "form", 
      "supply", 
      "conversion", 
      "treatment", 
      "donors", 
      "hematopathology", 
      "chapter", 
      "source", 
      "nature", 
      "investigation", 
      "detail", 
      "blood", 
      "investigators", 
      "state", 
      "anemia", 
      "years", 
      "trends", 
      "researchers", 
      "technology", 
      "applications", 
      "therapy", 
      "dependency", 
      "basics", 
      "transplantation", 
      "blood donors", 
      "thrombocytopenia", 
      "patients", 
      "platelet transfusions", 
      "standard treatment", 
      "appeal", 
      "contemporary forms", 
      "transfusion", 
      "imagination", 
      "blood transfusion"
    ], 
    "name": "Generating Blood from iPS Cells", 
    "pagination": "399-420", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1083691788"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-39562-3_19"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-39562-3_19", 
      "https://app.dimensions.ai/details/publication/pub.1083691788"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-10-01T06:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/chapter/chapter_260.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-39562-3_19"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-39562-3_19'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-39562-3_19'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-39562-3_19'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-39562-3_19'


 

This table displays all metadata directly associated to this object as RDF triples.

153 TRIPLES      22 PREDICATES      93 URIs      84 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-39562-3_19 schema:about anzsrc-for:06
2 anzsrc-for:0601
3 anzsrc-for:11
4 anzsrc-for:1102
5 schema:author N9a244883112f444d9fa1fe8c46b2c182
6 schema:datePublished 2016
7 schema:datePublishedReg 2016-01-01
8 schema:description Blood transfusions are the oldest contemporary form of cell therapy and remain the standard treatment for anemia and thrombocytopenia. Due to the enucleate nature of the cells, patients that require erythrocyte or platelet transfusions must rely on a constant supply of blood donors. Aging populations and other demographic trends, however, make this dependency unsustainable. Consequently, investigators have sought other sources for these cell types. Despite only being discovered 10 years ago, induced pluripotent stem cells (iPSCs) have quickly gained the imagination of researchers seeking new clinical treatments for an assortment of diseases, including hematopathologies. The appeal of iPSCs is that they permit the conversion of any cell in the body to another type. This cell reprogramming makes it possible to conduct autologous transplantation by taking cells such as fibroblasts from the patient and converting them to erythrocytes or platelets before reintroduction. iPSCs also allow for investigations on hematopoiesis that were previously impossible, as they enable each intermediate step in the development of a blood cell to be controlled and therefore studied in greater detail. In this chapter, we review the basics about cell reprogramming to the iPSC state and the application of this technology to generating erythrocytes and platelets ex vivo.
9 schema:editor N800316b6d1d74d75916ecb3be2eb025a
10 schema:genre chapter
11 schema:isAccessibleForFree false
12 schema:isPartOf Nfeb797f284c64f429a1c0f17a712b494
13 schema:keywords anemia
14 appeal
15 applications
16 assortment
17 assortment of diseases
18 autologous transplantation
19 basics
20 blood
21 blood cells
22 blood donors
23 blood transfusion
24 body
25 cell reprogramming
26 cell therapy
27 cell types
28 cells
29 chapter
30 clinical treatment
31 constant supply
32 contemporary forms
33 conversion
34 demographic trends
35 dependency
36 detail
37 development
38 disease
39 donors
40 erythrocytes
41 fibroblasts
42 form
43 greater detail
44 hematopathology
45 hematopoiesis
46 iPS cells
47 iPSC state
48 iPSCs
49 imagination
50 imagination of researchers
51 intermediate step
52 investigation
53 investigators
54 nature
55 new clinical treatments
56 patients
57 platelet transfusions
58 platelets
59 pluripotent stem cells
60 population
61 reintroduction
62 reprogramming
63 researchers
64 source
65 standard treatment
66 state
67 stem cells
68 step
69 supply
70 technology
71 therapy
72 thrombocytopenia
73 transfusion
74 transplantation
75 treatment
76 trends
77 types
78 vivo
79 years
80 schema:name Generating Blood from iPS Cells
81 schema:pagination 399-420
82 schema:productId N68f186e425064b9c880fb58d83ed4a60
83 N6ed560a8b21444899f96c481c26aba20
84 schema:publisher N326e993636874ab5b5ffcc29fdff52a3
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083691788
86 https://doi.org/10.1007/978-3-319-39562-3_19
87 schema:sdDatePublished 2022-10-01T06:55
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher Nfdfd447fe4aa43eea06ff8b8100f5e52
90 schema:url https://doi.org/10.1007/978-3-319-39562-3_19
91 sgo:license sg:explorer/license/
92 sgo:sdDataset chapters
93 rdf:type schema:Chapter
94 N326e993636874ab5b5ffcc29fdff52a3 schema:name Springer Nature
95 rdf:type schema:Organisation
96 N3535c5cca39b419a9b3ec94fde668e26 schema:familyName Italiano
97 schema:givenName Joseph
98 rdf:type schema:Person
99 N3f20f63f03b84c158d62228a12694205 rdf:first N3535c5cca39b419a9b3ec94fde668e26
100 rdf:rest rdf:nil
101 N68f186e425064b9c880fb58d83ed4a60 schema:name doi
102 schema:value 10.1007/978-3-319-39562-3_19
103 rdf:type schema:PropertyValue
104 N6ed560a8b21444899f96c481c26aba20 schema:name dimensions_id
105 schema:value pub.1083691788
106 rdf:type schema:PropertyValue
107 N6fcdfaefa67346438dd77af986a26f58 schema:familyName Schulze
108 schema:givenName Harald
109 rdf:type schema:Person
110 N800316b6d1d74d75916ecb3be2eb025a rdf:first N6fcdfaefa67346438dd77af986a26f58
111 rdf:rest N3f20f63f03b84c158d62228a12694205
112 N922c8fa7d4744539918864ba7b9f1236 rdf:first sg:person.0672274253.12
113 rdf:rest Ne52bc03e1d7a499696944fa4a8aa6c13
114 N9a244883112f444d9fa1fe8c46b2c182 rdf:first sg:person.01312262664.41
115 rdf:rest N922c8fa7d4744539918864ba7b9f1236
116 Ne52bc03e1d7a499696944fa4a8aa6c13 rdf:first sg:person.01062427654.09
117 rdf:rest rdf:nil
118 Nfdfd447fe4aa43eea06ff8b8100f5e52 schema:name Springer Nature - SN SciGraph project
119 rdf:type schema:Organization
120 Nfeb797f284c64f429a1c0f17a712b494 schema:isbn 978-3-319-39560-9
121 978-3-319-39562-3
122 schema:name Molecular and Cellular Biology of Platelet Formation
123 rdf:type schema:Book
124 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
125 schema:name Biological Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
128 schema:name Biochemistry and Cell Biology
129 rdf:type schema:DefinedTerm
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
134 schema:name Cardiorespiratory Medicine and Haematology
135 rdf:type schema:DefinedTerm
136 sg:person.01062427654.09 schema:affiliation grid-institutes:grid.258799.8
137 schema:familyName Eto
138 schema:givenName Koji
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062427654.09
140 rdf:type schema:Person
141 sg:person.01312262664.41 schema:affiliation grid-institutes:grid.258799.8
142 schema:familyName Karagiannis
143 schema:givenName Peter
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312262664.41
145 rdf:type schema:Person
146 sg:person.0672274253.12 schema:affiliation grid-institutes:grid.258799.8
147 schema:familyName Endo
148 schema:givenName Hiroshi
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672274253.12
150 rdf:type schema:Person
151 grid-institutes:grid.258799.8 schema:alternateName Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan
152 schema:name Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, 606-8507, Kyoto, Japan
153 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...